| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |